CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-14 | Manning Paul B Director | Purchase | +50,000 | $6.51 | $326K | 1,465,719 |
| 2020-08-13 | Stalfort Sean Director | Purchase | +15,550 | $6.45 | $100K | 446,410 |
| 2020-08-13 | DAVIS A BRIAN Chief Financial Officer | Purchase | +7,900 | $6.24 | $49K | 7,900 |
| 2020-08-13 | White Ted President and CEO | Purchase | +10,661 | $6.28 | $67K | 17,966 |
| 2020-08-13 | Manning Paul B Director | Purchase | +108,500 | $6.41 | $695K | 1,415,719 |
| 2020-08-01 | Goldenberg Gary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2020-08-01 | Eichenfield Lawrence Director | Grant or award · Stock Option (right to buy) | +17,502 | 17,502 | ||
| 2020-06-11 | Goldenberg Gary Director | Grant or award · Option Grant (right to buy) | +5,834 | 5,834 | ||
| 2020-06-11 | Ballaron Craig Director | Grant or award · Option Grant (right to buy) | +5,834 | 5,834 | ||
| 2020-06-11 | PRYGOCKI MARK A SR Director | Grant or award · Option Grant (right to buy) | +5,834 | 5,834 | ||
| 2020-06-09 | Nguyen Diem Director | Grant or award · Stock Option (right to buy) | +17,502 | 17,502 | ||
| 2020-02-27 | Hayes Christopher G. General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-02-27 | White Ted President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2020-02-27 | DAVIS A BRIAN Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-02-27 | Burnett Patrick Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-02-27 | Bonaccorso Joe Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-10-18 | DAVIS A BRIAN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2019-10-10 | Manning Paul B Director | Purchase | +6,900 | $15.05 | $104K | 8,079,394 |
| 2019-10-09 | Manning Paul B Director | Purchase | +8,778 | $14.06 | $123K | 8,072,494 |
| 2019-10-08 | Manning Paul B Director | Purchase | +5,208 | $14.02 | $73K | 8,063,716 |
Page 10 of 19 · 372 trades